| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/02/2000 | CA2340928A1 Novel arylsulphonamides and analogues |
| 03/02/2000 | CA2340785A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 03/02/2000 | CA2340692A1 Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 03/02/2000 | CA2340616A1 Secreted proteins and polynucleotides encoding them |
| 03/02/2000 | CA2340327A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 03/02/2000 | CA2340277A1 Human rna-associated proteins |
| 03/02/2000 | CA2339860A1 Human cell signaling proteins (csig) |
| 03/02/2000 | CA2339775A1 Vitamin d3 mimics |
| 03/02/2000 | CA2339537A1 Regulation of substrate activity |
| 03/01/2000 | EP0982405A2 Recombinant alphavirus vectors |
| 03/01/2000 | EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| 03/01/2000 | EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 03/01/2000 | EP0981612A2 Secreted proteins and polynucleotides encoding them |
| 03/01/2000 | EP0981550A1 Methods for eosinophil depletion and compositions therefor |
| 03/01/2000 | EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/01/2000 | EP0981375A1 Pharmaceutical compositions containing plasma protein |
| 03/01/2000 | EP0981371A1 Green porphyrins as immunomodulators |
| 03/01/2000 | EP0769020B1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 03/01/2000 | EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
| 03/01/2000 | EP0513387B1 Thiazole derivatives as active oxygen inhibitors |
| 03/01/2000 | CN1246125A Peptides comprising a T-cell epitope specific to collagen II |
| 03/01/2000 | CN1246121A Immunosuppressive compounds and methods |
| 03/01/2000 | CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments |
| 03/01/2000 | CN1246109A 5-aroylnaphthalene derivatives |
| 03/01/2000 | CN1246058A Oil-free pharmaceutical compositions containing cyclosporin A |
| 03/01/2000 | CN1246057A Oral cyclosporin formulations |
| 03/01/2000 | CN1246056A Mycobacterium vaccae for down-regulation of THz activity of immune system |
| 03/01/2000 | CN1245720A Medicinal composition containing calcineurin B subunit |
| 03/01/2000 | CN1245689A Preparation method of bee afterbirth extract (bee frison extract) and its application |
| 03/01/2000 | CN1049818C Pharmaceutical use of benzo-thiophenes compound |
| 03/01/2000 | CA2246791A1 Treatment of endothelium with somatostatin analogues |
| 02/29/2000 | US6031133 Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof |
| 02/29/2000 | US6031080 Chemotactic cytokine |
| 02/29/2000 | US6031072 Compounds and methods for modulating cell adhesion |
| 02/29/2000 | US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse; |
| 02/29/2000 | US6030946 Reversible cysteine protease inhibitors |
| 02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
| 02/29/2000 | US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents |
| 02/29/2000 | US6030790 Kit for detecting active human parathyroid hormone including two sets of antibodies or antibody fragments; for diagnosis |
| 02/29/2000 | US6030624 Mucosal immunogens for novel vaccines |
| 02/29/2000 | US6030622 Herbal extract composition and method with immune-boosting capability |
| 02/29/2000 | US6030618 Therapeutic and prophylactic methods using heat shock proteins |
| 02/29/2000 | US6030614 Passing plasma of human recipient over column to effect binding of anti-human immunoglobulins antibodies to immunoglobulin in recipient's blood and recovering an effluent, reinfusing effluent |
| 02/29/2000 | US6030613 Receptor specific transepithelial transport of therapeutics |
| 02/29/2000 | US6030612 Antimicrobial uses of multifunctional enzyme |
| 02/29/2000 | CA2117349C Benzopyrans and related ltb4 antagonists |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/29/2000 | CA1340915C Myeloperoxydase humaine et application therapeutique |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009733A1 Intracellular delivery vehicles |
| 02/24/2000 | WO2000009709A2 Proteases and associated proteins |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009616A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009512A2 Bipyridine manganese complexes |
| 02/24/2000 | WO2000009510A1 Photocyclized rapamycins |
| 02/24/2000 | WO2000009507A1 Phenyl yanthine derivatives |
| 02/24/2000 | WO2000009506A1 1h-imidazopyridine derivatives |
| 02/24/2000 | WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 02/24/2000 | WO2000009492A1 Tace inhibitors |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009479A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009159A1 Compositions of cpg and saponin adjuvants and methods thereof |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009155A1 Methods and compositions for preventing anti-gal production in xenograft recipients |
| 02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |
| 02/24/2000 | WO2000009150A2 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use |
| 02/24/2000 | WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009103A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | WO2000009102A2 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 02/24/2000 | WO2000001345A3 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
| 02/24/2000 | WO1999057133A3 Inhibitors of nf-kb activation |
| 02/24/2000 | WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | DE19938394A1 Immunoadsorber for removing endotoxins from fluids uses avian endotoxin antibodies |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19834610A1 New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340700A1 Photocyclized rapamycins |
| 02/24/2000 | CA2340668A1 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | CA2340419A1 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 02/24/2000 | CA2340350A1 Phenyl yanthine derivatives |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339562A1 1h-imidazopyridine derivatives |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |